DePuy Trochanteric (ATN) Nailing Clinical Outcomes Trial

NCT ID: NCT00546429

Last Updated: 2023-06-06

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

62 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-09-01

Study Completion Date

2009-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to monitor trochanteric fracture healing and review the performance of the ATN system.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Proximal femoral fractures are among the most common femoral fractures. In the past plates and screws were often used to repair these fractures but this treatment had limitations including restricted weight bearing. Intermedullary nailing is an alternative to plate and screw treatment. Weight bearing is allowed and the procedure can be a less invasive. Among intramedullary nailing complications are iatrogenic fractures that can be further divided into trochanteric and femoral shaft fractures. Trochanteric fractures often heal without additional intervention however femoral shaft fractures usually require an additional surgical procedure to facilitate healing. This study will monitor fracture healing using clinical and radiographic evaluations of subjects with trochanteric fractures of the proximal femur treated with the ATN system.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Femoral Fracture (Proximal)

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

A

Monitoring of trochanteric fractures after treatment with the ATN system.

Intramedullary nailing

Intervention Type DEVICE

Trochanteric nailing for proximal femoral fractures.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Intramedullary nailing

Trochanteric nailing for proximal femoral fractures.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Ace Trochanteric Nail (ATN) system

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Ability to understand and willing to sign the approved consent form.
* 18 years of age
* Skeletally mature
* Have stable or unstable proximal femur fracture, including pertrochanteric, intertrochanteric, high subtrochanteric or any combination of the AO Proximal Femur Fracture Classification

Exclusion Criteria

* Subjects with concomitant lower extremity injuries or multiple trauma that would interfere with normal hip fracture rehabilitation.
* Subjects who have isolated or combined medial femoral neck fractures.
* Subjects who are unwilling or unable to comply with a rehabilitation program or are unwilling or unable to be assessed for 1 year following surgery.
* Subjects who are pregnant or breastfeeding.
* Subjects who are a prisoner or a known alcohol or drug abuser.
* Subjects who have a prior surgical history in the affected hip, or conditions that may interfere with outcome or impede healing.
* Subjects who have an obliterated medullary canal or other conditions that may complicate the reaming process.
* Subjects who have evidence of active untreated infections that may spread to other areas of the body.
* Subjects who have a highly communicable disease or pathology that may limit follow-up.
* Subjects, who in the opinion of the Clinical Investigator, have an existing condition that indicates the Subject is not a good candidate for the study.
* Subjects who are participating in another clinical investigation.
* Subjects known to have allergies to titanium, aluminum, vanadium.
* Subjects who are currently eligible for workman's compensation.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

DePuy Orthopaedics

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Sam Himden

Role: STUDY_DIRECTOR

DePuy Orthopaedics

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Front Range Orthopaedics

Colorado Springs, Colorado, United States

Site Status

Orthopaedic Physicians of Colorado

Englewood, Colorado, United States

Site Status

Erie County Medical Center

Buffalo, New York, United States

Site Status

Blue Ridge Bone and Joint

Asheville, North Carolina, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

04077

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.